AI has the potential to transform the speed, sophistication, and safety of drug discovery, yielding better medicines and vaccines. Companies need to train complex models using huge datasets quickly to be successful. Researchers need results in minutes or hours instead of days or months to run many experiments to test their hypotheses. In this interview, we talk with Andy Hock, VP of Product for Cerebras Systems – maker of the world’s fastest AI accelerator – about removing roadblocks to biomedical research, drug discovery and data-driven healthcare and how Cerebras is helping to solve big problems at GSK, AstraZeneca and other leading pharma and healthcare organizations.
About Dr. Andy Hock
Andy Hock is VP of Product Management at Cerebras Systems. Andy was the Senior Director of Advanced Technologies at Skybox Imaging, makers of high-resolution satellites when the company was purchased by Google in 2014. He holds a Ph.D. in Geophysics and Space Physics from UCLA.
About Cerebras Systems
Cerebras Systems is a team of pioneering computer architects, computer scientists, deep learning researchers, and engineers of all types. We have come together to build a new class of computer system, designed for the singular purpose of accelerating AI and changing the future of AI work forever. Our flagship product, the CS-2 system is powered by the world’s largest processor – the 850,000 core Cerebras WSE-2, which enables customers to accelerate their deep learning work by orders of magnitude over general-purpose compute. For more information, visit https://Cerebras.net
About Next Digital Health
Next Digital Health is your healthcare technologies and wellness technologies site. We provide you with the latest technology news and videos straight from the healthcare, pharmacy and wellness industries. Next Digital Health is an initiative of Wi4 (https://wi4.org). Wi4 is is on a mission to positively impact the future of health by designing innovative products with cutting-edge technology that are beautiful, experience-driven, and safe.
